The Low-Density Lipoprotein (LDL) Receptor is a mosaic protein of 839 amino acids (after removal of 21-amino acid signal peptide) that mediates the endocytosis of cholesterol-rich LDL. It is a cell-surface receptor that recognizes the apoprotein B100, which is embedded in the outer phospholipid layer of LDL particles. The receptor also recognizes the apoE protein found in chylomicron remnants and VLDL remnants (IDL). In humans, the LDL receptor protein is encoded by the LDLRgene. It belongs to the Low density lipoprotein receptor gene family.
“On the surface of the liver you have LDL receptors, which are responsible for the metabolism of cholesterol,” says McGrath ... This boost in LDL receptors also happens when you take statins.
“On the surface of the liver you have LDL receptors, which are responsible for the metabolism of cholesterol,” says McGrath ... This boost in LDL receptors also happens when you take statins.
It is a small interfering RNA (siRNA) therapy that targets a liver protein called PCSK9 (proprotein convertase subtilisin kexin type 9), which normally limits the number of receptors that remove LDL cholesterol from the bloodstream.